Skip to content

Efficacy of a Device for Training Metered Dose Inhaler Breathing Proficiency: A Crossover, Double-blind, Pilot Trial in Healthy Volunteers.

Efficacy of a Device for Training Metered Dose Inhaler Breathing Proficiency: A Crossover, Double-blind, Pilot Trial in Healthy Volunteers.

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240401004
Enrollment
30
Registered
2024-04-01
Start date
2024-04-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metered dose inhaler (MDI) breathing proficiency Metered Dose Inhalers

Interventions

NUB (NU_spiroBreathe ) is a validated device specifically designed to measure respiratory force.,pMDI is a placebo-metered dose inhaler,NaMDI is a NUB-assisted MDI.
Experimental Device,Placebo Comparator Device,Experimental Device
NUB,pMDI,NaMDI.

Sponsors

The Medical and Pharmacy Innovation Research Unit, Naresuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. healthy university students, 2. aged 18 years or above.

Exclusion criteria

Exclusion criteria: 1. had been diagnosed with chronic airway diseases, 2. ongoing acute airway diseases, 3. had experiences with inhalation medications, 4. had known hypersensitivity reactions to plastic.

Design outcomes

Primary

MeasureTime frame
MDI breathing proficiency simultaneously (at the time participants use the device) differences in inhalation time and inhalation force

Secondary

MeasureTime frame
cardiopulmonary safety of NUB immediately after the participants use the device BP, HR, and SpO2

Countries

Thailand

Contacts

Public ContactPrayuth Poowaruttanawiwit

The Medical and Pharmacy Innovation Research Unit

yuth_pu@hotmail.com0863991002

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026